Le Lézard
Classified in: Health, Business
Subjects: LEG, VET, STP

Larson to visit Fidelco Guide Dog Foundaiton with Newman's Own


HARTFORD, Conn., Feb. 23, 2018 /PRNewswire-PRWeb/ -- On Friday, February 23rd at 12pm, Rep. John B. Larson (CT-01) will join Bob Forrester, the President and CEO of the Newman's Own Foundation and Eliot Russman President, CEO and Executive Director of Fidelco Guide Dog Foundation at the Fidelco headquarters in Bloomfield to discuss the recent passing of his bill, the Philanthropic Enterprise Act, into law and its positive impact for the future of companies like Newman's Own that donate 100 percent of their profits to charitable organizations, like the Fidelco Guide Dog Foundation that serve the blind and blind veterans.

The Philanthropic Enterprise Act was recently passed as a part of the Bipartisan Budget Act of 2018 and was signed into law. This was a terrific win for Connecticut, the country, companies like Newman's Own, and the charitable organizations that benefit from philanthropic enterprises. For several years, Larson led the effort in the House, along with his colleague Rep. Dave Reichert (R-WA), to pass legislation to provide a small technical fix in the tax code to support, rather than stand as a barrier to, socially-responsible companies like Newman's Own and the dozens of other philanthropic businesses they have inspired. The passing of this legislation was testament to what can be achieved through bipartisan efforts in Washington D.C. and what can be ultimately accomplished for the country.

Who:
Rep. Larson, Bob Forrester (President, CEO of the Newman's Own Foundation), Eliot Russman (President & CEO Fidelco), and Don Overton, Fidelco client and battle blinded Veteran (Spcl, U.S. Army, 82nd Airborne, Ret)

What:
Tour and Speaking Event

When/Where:
Friday, Feb. 23rd
12 pm
Fidelco Guide Dog Foundation, Inc.
103 Vision Way
Bloomfield, CT 06002

 

SOURCE Fidelco Guide Dog Foundation


These press releases may also interest you

at 09:05
LumaBridge, a clinical research organization (CRO) dedicated to discovering, developing, and testing emerging biotechnologies related to cancer therapies, today announced the appointment of Todd Lehman as Chief Executive Officer, President and member...

at 09:05
Ontada®, a McKesson business dedicated to leveraging oncology real-world data and evidence, clinical education, and provider technology, announced the appointment of Jade Cusick as its new Chief Commercial Officer and member of the Ontada leadership...

at 09:05
Artiva Biotherapeutics, Inc., a clinical-stage company whose mission is to deliver broadly accessible, off-the-shelf natural killer (NK) cell-based therapies to patients suffering from devastating autoimmune diseases and cancers, today announced the...

at 09:05
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation (GenScript), one of the world's leading providers of life-science research tools and...

at 09:00
This month, The Retreat at Sunbrook and The...

at 09:00
Lakeside Software, the leading IT data intelligence company, achieved 88 percent year-over-year growth for its first quarter of 2024. More than half of the Q1 contracts were with current customers, expanding their use of Lakeside's SysTrack platform...



News published on and distributed by: